When it comes to treating tumors, brain cancer research specialists can tell you that there is a great deal of attention that goes into the cells. More specifically, the ability to differentiate between the healthy and unhealthy cells is going to be given a great amount of focus. What are the tools that can be put to use in order to make this easier for surgeons, you may wonder? As it seems, a certain drug may be put to use in order to fulfill such a purpose.
To say that brain cancer research is broad would be nothing short of an understatement. It is clear that there will be a number of approaches to consider and certain drugs will be put to use more so than others. Of course, those who understand this level of research will be able to tell you that surgery, in this regard, can prove to be quite risky. This is why new methods are going to be looked into, as organizations along the lines of Voices against Brain Cancer can tell you.
An article was posted on YottaFire and it went into detail about the utilized drug dubbed J101. According to the article in question, J101 has the ability to not only stop the growth of cancerous cells in the body but do so while leaving the healthy cells unaffected. To say that this possesses a great deal of success for the future would be nothing short of an understatement. Of course, many of you are probably wondering, specifically, why J101 is such a useful component for this purpose.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
It's clear that this field is going to have a great deal of attention drawn to it, as many others will attest to. J101 is a drug that can work well for the purpose of differentiating between cells but it appears as though other drugs have come to the surface as well. Can these prove useful for some patients than they will for others? Whatever the case may be, the fact that they even exist means that the level of potential to be had is even greater.
To say that brain cancer research is broad would be nothing short of an understatement. It is clear that there will be a number of approaches to consider and certain drugs will be put to use more so than others. Of course, those who understand this level of research will be able to tell you that surgery, in this regard, can prove to be quite risky. This is why new methods are going to be looked into, as organizations along the lines of Voices against Brain Cancer can tell you.
An article was posted on YottaFire and it went into detail about the utilized drug dubbed J101. According to the article in question, J101 has the ability to not only stop the growth of cancerous cells in the body but do so while leaving the healthy cells unaffected. To say that this possesses a great deal of success for the future would be nothing short of an understatement. Of course, many of you are probably wondering, specifically, why J101 is such a useful component for this purpose.
J101's function is to block a cellular "messaging" molecule, a substance by the name of polo-like kinase 1. While this may not be familiar to most, plk1 has the ability to send messages to cancer cells in the body and cause them to multiply and progress, thereby resulting in the growth of tumors later on. J101 was the drug talked about but the report spoke about three new drugs that operate in the same way. Not only are they similar in this regard but they can also cross the bloodstream easier than J101.
It's clear that this field is going to have a great deal of attention drawn to it, as many others will attest to. J101 is a drug that can work well for the purpose of differentiating between cells but it appears as though other drugs have come to the surface as well. Can these prove useful for some patients than they will for others? Whatever the case may be, the fact that they even exist means that the level of potential to be had is even greater.
About the Author:
For extra knowledge in regards to brain cancer research and awareness in general, kindly consult Voices against Brain Cancer. Free reprint available from: Brain Cancer Research & Where Differentiating Cells Comes In.
No comments:
Post a Comment